Shareholding disclosure

Idorsia Pharmaceuticals Ltd

Declared position

18.45%

Threshold

Crossed upwards

Timeline

Published

29.09.2021

Transaction

24.09.2021

Voting rights breakdown

Voting rights acquired18.45%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL9S00051

Beneficial owner

Idorsia Pharmaceuticals Ltd

Declared address

Idorsia Pharmaceuticals Ltd, 4123 Allschwil

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open